Postpartum hemorrhage (PPH) is the leading preventable cause of maternal mortality worldwide, responsible for approximately 27% of maternal deaths globally. For nurses in labor and delivery, mother-baby, or ICU settings, the ability to recognize PPH early and respond with precision is a core clinical competency. This reference covers the complete PPH framework: how it is defined, what causes it, how to assess it, and how to intervene — in the order that matters in an emergency.
| PPH at a glance | Key facts |
|---|---|
| Primary PPH definition | Blood loss ≥500 mL (vaginal delivery) or ≥1,000 mL (cesarean) within 24 hours of birth, OR any amount causing hemodynamic instability |
| Secondary PPH definition | Abnormal bleeding from 24 hours to 12 weeks postpartum |
| Leading cause | Uterine atony (Tone) — responsible for ~80% of PPH cases |
| First-line intervention (uterine atony) | Uterine/fundal massage + oxytocin IV |
| Critical lab predictor | Fibrinogen <200 mg/dL predicts progression to severe PPH |
| TXA timing rule | Tranexamic acid must be given within 3 hours of birth to be effective (WHO recommendation) |
The 4 T’s framework
Every case of PPH has one or more root causes. The 4 T’s framework — Tone, Trauma, Tissue, Thrombin — gives nurses and providers a systematic way to identify and treat the source simultaneously.
Tone: uterine atony (~80% of PPH)
Uterine atony occurs when the myometrium fails to contract after delivery. Normally, the uterus contracts firmly to compress the uterine sinuses and stop bleeding from the placental implantation site. When tone is lost, those sinuses remain open and hemorrhage is rapid.
Assessment findings: The fundus feels soft, boggy, or difficult to locate. Blood loss is rapid and often underestimated visually. The uterus may be displaced laterally (usually right) by a full bladder — always have the patient void or insert a catheter before re-assessing fundal tone.
Intervention priority: Begin fundal massage immediately. Use the non-dominant hand suprapubically to stabilize the lower uterine segment, then cup the fundus with the dominant hand and massage in firm, circular motions. A well-contracted uterus should feel firm, approximately the size of a grapefruit, at or below the umbilicus. Do not massage a uterus that is already firm — this causes pain without benefit and can cause uterine fatigue.
If massage alone does not restore tone within 15 seconds, escalate to bimanual compression and uterotonics (see Medications section below).
Trauma: lacerations, hematoma, uterine rupture, uterine inversion
Trauma-related PPH occurs even when the uterus is firmly contracted. Any patient bleeding despite a well-contracted, midline fundus should be evaluated for traumatic causes.
- Lacerations: Cervical, vaginal, or perineal lacerations can produce substantial bleeding that requires direct visualization and surgical repair. Lacerations are especially common after operative vaginal delivery (forceps or vacuum).
- Hematomas: Concealed bleeding into tissue planes (vulvar, vaginal, paravaginal) may not be visible externally. Signs include unrelenting perineal or pelvic pain, a palpable mass, and vital sign changes disproportionate to visible blood loss.
- Uterine rupture: Rare but catastrophic, most common in patients with a prior uterine scar (prior cesarean, myomectomy). Presents with sudden severe abdominal pain, loss of fetal station, and hemodynamic collapse.
- Uterine inversion: The uterine fundus turns inside out through the cervix, usually during excessive cord traction or fundal pressure on an uncontracted uterus. Requires immediate manual reduction — do not remove the placenta before reduction, as the placenta helps maintain pressure while the uterus is repositioned.
Tissue: retained placenta and membranes
Retained placental fragments or membranes prevent the uterus from contracting fully. The placenta should deliver within 30 minutes of birth. If it does not, or if the delivered placenta appears incomplete (missing cotyledons or a disrupted membrane edge), manual exploration of the uterine cavity is required.
Secondary PPH — bleeding that begins more than 24 hours after delivery and up to 12 weeks postpartum — is most often caused by subinvolution of the uterus due to retained tissue or endometritis.
Thrombin: coagulopathy
Coagulopathy can be a primary cause of PPH or develop secondarily as massive hemorrhage consumes clotting factors. Key presentations include:
- DIC: Often triggered by obstetric conditions such as placental abruption, amniotic fluid embolism, severe preeclampsia, or sepsis. Labs show elevated PT/aPTT, elevated D-dimer, decreased platelets, and critically low fibrinogen. For the full DIC framework, see the nursing lab values cheat sheet.
- Von Willebrand disease: The most common inherited bleeding disorder in women. Patients may present with PPH as their first significant bleeding episode.
- Dilutional coagulopathy: Develops when massive crystalloid resuscitation dilutes clotting factors — another reason balanced blood product resuscitation (1:1:1 protocol) is preferred over crystalloid-only management.
Risk factors
| Category | Risk factor | Mechanism |
|---|---|---|
| Uterine (Tone) | Grand multiparity (≥5 deliveries) | Uterine muscle becomes less responsive to oxytocin over successive pregnancies |
| Uterine (Tone) | Overdistended uterus (multiple gestation, polyhydramnios, macrosomia) | Overstretched myometrium contracts less effectively |
| Uterine (Tone) | Prolonged labor or labor augmentation with oxytocin | Uterine fatigue; oxytocin receptor downregulation |
| Uterine (Tone) | Chorioamnionitis (intrauterine infection) | Inflammatory mediators impair myometrial contractility |
| Placental (Tissue) | Placenta previa | Lower uterine segment contracts poorly; abnormal implantation site |
| Placental (Tissue) | Placenta accreta spectrum (accreta, increta, percreta) | Abnormal placental invasion prevents normal separation; cesarean hysterectomy often required |
| Placental (Tissue) | Retained placental fragments | Prevents uterine contraction; ongoing bleeding from exposed sinuses |
| Trauma | Operative vaginal delivery (forceps, vacuum) | Increased risk of lacerations, hematoma, and soft tissue injury |
| Trauma | Prior uterine surgery (cesarean, myomectomy) | Uterine scar increases rupture risk; accreta risk increases with each prior cesarean |
| Coagulation (Thrombin) | Pre-existing coagulopathy (von Willebrand, thrombocytopenia) | Impaired primary or secondary hemostasis |
| Coagulation (Thrombin) | Anticoagulant therapy (heparin, low-molecular-weight heparin) | Direct pharmacologic impairment of clotting |
| Coagulation (Thrombin) | Previous postpartum hemorrhage | Strongest single predictor of recurrence; uterine atony risk is significantly elevated |
Clinical assessment
Fundal assessment and massage technique
Position the patient supine with the head of bed flat. Empty the bladder first (ask patient to void, or insert a urinary catheter) — a full bladder displaces the uterus and causes a false impression of poor tone. With gloves on:
- Place the non-dominant hand flat above the pubic symphysis to stabilize the lower uterine segment and prevent uterine inversion.
- Palpate for the fundus with the dominant hand. In the first hour after delivery, the fundus should be firm and at or one fingerbreadth below the umbilicus.
- If boggy (soft, spongy), massage firmly in a circular pattern until the fundus becomes firm.
- Note any blood expressed — clots and fluid expressed during massage are measured as part of quantitative blood loss.
Quantitative blood loss vs. visual estimation
Quantitative blood loss (QBL) is the standard of care and is more accurate than visual estimation. Studies show nurses and physicians consistently underestimate blood loss by 30–50% when using visual assessment alone — a dangerous pattern that delays intervention.
QBL methods:
- Gravimetric weighing: Weigh all blood-soaked materials (pads, drapes, linens) on a calibrated scale. Subtract the dry weight of each item. 1 gram = approximately 1 mL of blood.
- Volumetric collection: Use calibrated under-buttock drapes that pool and measure blood loss directly.
- Combined: Many facilities use gravimetric for saturated materials plus volumetric collection for pooled blood.
Document QBL in real time. Cumulative tracking is more reliable than point-in-time estimates. For lab interpretation related to blood loss, see the nursing lab values cheat sheet.
Signs of hypovolemic shock
Early recognition of hemodynamic compromise is critical. Vital sign changes often lag behind actual volume loss — by the time the blood pressure drops, a patient may have lost 25–30% of their circulating blood volume.
Assess in this order: mental status → skin → pulse → blood pressure → urine output. For a complete framework on shock recognition and staging, see the shock nursing reference.
Lab values in PPH:
- Fibrinogen: A level below 200 mg/dL is an early and highly specific predictor of severe PPH requiring massive transfusion. Serial fibrinogen levels should be drawn as hemorrhage progresses.
- CBC: Hemoglobin and hematocrit lag actual volume status during acute hemorrhage — a normal H&H in the first 30 minutes does not rule out significant blood loss.
- PT/aPTT and D-dimer: Elevated values suggest evolving coagulopathy or DIC.
- Platelet count: Watch for consumption — platelets below 50,000/µL impairs hemostasis significantly.
- BMP/BMP: Monitor renal perfusion (creatinine, BUN) as volume status worsens.
Uterotonic medications
| Drug | Dose and route | Mechanism | Contraindications | Key nursing considerations |
|---|---|---|---|---|
| Oxytocin (Pitocin) | 10–40 units in 500–1,000 mL NS or LR IV infusion; or 10 units IM | Binds oxytocin receptors in myometrium → stimulates uterine contraction | None absolute for PPH; use caution with IV bolus in hypotensive patients (causes vasodilation) | First-line agent. Never give as undiluted IV push — causes severe hypotension and reflex tachycardia. Run as rapid infusion. Monitor fluid balance for water intoxication with high doses (antidiuretic effect). |
| Methylergonovine (Methergine) | 0.2 mg IM; may repeat every 2–4 hours | Ergot alkaloid → sustained uterine and vascular smooth muscle contraction | Contraindicated in hypertension (including preeclampsia, chronic HTN) — causes severe vasoconstriction and hypertensive crisis | Second-line agent after oxytocin. Check BP before administration. Do not give IV (risk of sudden hypertension and stroke). Stored in refrigerator — confirm it has been kept cold before use. |
| Carboprost (Hemabate) | 0.25 mg IM; may repeat every 15–90 min, max 8 doses | 15-methyl prostaglandin F2α → potent uterine contraction; also bronchoconstrictive | Contraindicated in asthma (can precipitate bronchospasm); use with caution in cardiac disease, hypertension | Most potent uterotonic available. Common side effects: nausea, vomiting, diarrhea (pre-medicate with antiemetic). Have bronchodilator available. Monitor O2 saturation. |
| Misoprostol (Cytotec) | 800–1,000 mcg rectally or 600 mcg sublingually | Prostaglandin E1 analogue → uterine contraction; less potent than carboprost | No absolute contraindications for PPH treatment route; caution with prior uterine scar if used for induction | Useful when IV access is unavailable or other uterotonics are contraindicated. Rectal route preferred in unconscious patients. Causes shivering and fever — reassure patient. Room-temperature stable (advantage over other agents). |
| Tranexamic acid (TXA) | 1 g IV over 10 minutes; may repeat once within 30 minutes if bleeding continues | Antifibrinolytic — blocks plasminogen binding to fibrin, preventing clot breakdown | History of thromboembolic disease (relative); seizure history at high doses | Must be given within 3 hours of birth (per WHO WOMAN trial evidence) — after 3 hours, benefit is lost and risk of thrombosis increases. TXA does not cause uterine contraction — it preserves existing clots. Administer in addition to uterotonics, not instead of them. |
Priority nursing interventions
These are listed in the order you perform them in a real PPH emergency — not alphabetically, not by department, but by what saves lives first.
1. Call for help immediately. The first moment you identify PPH or suspect it, activate your team. Do not wait for vital signs to change. PPH can progress from manageable to catastrophic in minutes. Activate your institution’s PPH protocol or massive transfusion protocol as appropriate.
2. Establish IV access — two large-bore IVs. Use 16-gauge or larger peripheral IV catheters, one in each antecubital fossa if possible. Large-bore access is required for rapid fluid and blood product administration. See the IV insertion guide for technique under difficult access conditions.
3. Begin uterine massage. As described above — stabilize the lower uterine segment, massage the fundus firmly until contracted, and express clots. This is the first nursing action for uterine atony and must happen before reaching for medications.
4. Administer oxytocin. First-line pharmacologic agent. Prepare as directed by your institutional protocol. Do not administer as an undiluted IV push.
5. Initiate fluid resuscitation. Warm crystalloid (NS or LR) at a rapid rate while blood products are being prepared. However, avoid crystalloid-only resuscitation in severe PPH — it dilutes clotting factors and worsens coagulopathy. Transition to blood products (packed red blood cells, FFP, platelets) as quickly as possible.
6. Apply oxygen. Non-rebreather mask at 10–15 L/min for patients showing hemodynamic compromise. Maintain SpO2 ≥95%.
7. Position the patient. Supine or modified Trendelenburg (legs elevated 15–30°) to maximize venous return. Avoid Trendelenburg in patients with respiratory compromise — it impairs diaphragm excursion.
8. Keep the patient warm. Hypothermia impairs coagulation — the clotting cascade is temperature-dependent. Apply warm blankets, use warmed IV fluids, and minimize unnecessary exposure. Target core temperature ≥36°C.
9. Insert a urinary catheter. Strict intake and output. Urine output below 30 mL/hour indicates inadequate renal perfusion and worsening hypovolemia. Bladder drainage also eliminates bladder distension as a contributor to uterine atony.
10. Draw labs and type and crossmatch. CBC, fibrinogen, PT/aPTT, D-dimer, BMP. Type and crossmatch for 2–4 units of packed red blood cells. Send simultaneously — do not wait until labs return to start other interventions.
11. Activate massive transfusion protocol (MTP) if indicated. MTP provides blood products in a balanced 1:1:1 ratio — 1 unit packed red blood cells (PRBCs): 1 unit fresh frozen plasma (FFP): 1 unit platelets. This ratio most closely approximates whole blood and prevents the dilutional coagulopathy caused by PRBCs alone. Cryoprecipitate (concentrated fibrinogen) is added when fibrinogen falls below 150–200 mg/dL.
12. Document continuously. Record time of hemorrhage identification, interventions given (with times and doses), quantitative blood loss totals, vital signs, and patient response. Accurate documentation is essential for handoff and for identifying when escalation thresholds are crossed.
Hemodynamic escalation triggers
| Parameter | Normal postpartum | Early warning (Stage 1–2 PPH) | Severe / escalate immediately |
|---|---|---|---|
| Heart rate | 60–100 bpm | 100–120 bpm | >120 bpm, especially if rising |
| Systolic BP | 100–130 mmHg | 80–100 mmHg | <80 mmHg or drop ≥30 mmHg from baseline |
| Mean arterial pressure (MAP) | 70–100 mmHg | 60–70 mmHg | <60 mmHg — inadequate organ perfusion pressure |
| Respiratory rate | 12–20 breaths/min | 20–30 breaths/min | >30 breaths/min or <10 breaths/min |
| SpO2 | ≥95% | 90–94% | <90% despite supplemental oxygen |
| Urine output | ≥30 mL/hr | 20–30 mL/hr | <20 mL/hr — renal hypoperfusion |
| Level of consciousness | Alert and oriented | Anxious, restless | Confused, obtunded — cerebral hypoperfusion |
| Capillary refill | <2 seconds | 2–3 seconds | >3 seconds — peripheral vasoconstriction/shock |
| Skin | Warm, pink, dry | Cool, pale, slightly diaphoretic | Cold, mottled, clammy — decompensated shock |
| Quantitative blood loss | <500 mL (vaginal) / <1,000 mL (cesarean) | 500–1,000 mL excess above threshold | >1,500 mL total or any hemodynamic instability — activate MTP |
NCLEX tips
1. QBL vs. visual estimation — always use quantitative blood loss. NCLEX scenarios that describe a nurse estimating blood loss by looking at a pad are describing substandard practice. The correct answer is always gravimetric weighing or volumetric collection. Visual estimation underestimates blood loss by 30–50%, which delays recognition and intervention.
2. Methylergonovine is contraindicated in hypertension — no exceptions. Methylergonovine (Methergine) causes vasoconstriction in addition to uterine contraction. In a patient with preeclampsia, chronic hypertension, or any elevated blood pressure, it can precipitate hypertensive crisis or stroke. The NCLEX will test this contraindication directly. If the question involves a postpartum patient with elevated BP who is hemorrhaging, methylergonovine is never the right answer. For the full context on maternal hypertension, see the hypertension nursing guide.
3. Tranexamic acid must be given within 3 hours of birth. TXA is an antifibrinolytic — it prevents breakdown of existing clots. The WHO WOMAN trial demonstrated that when TXA is given within 3 hours of birth, it reduces mortality from PPH. After 3 hours, the window is closed and administration increases thrombosis risk without hemostatic benefit. NCLEX will test the 3-hour rule.
4. Fibrinogen below 200 mg/dL predicts severe PPH. A fibrinogen level below 200 mg/dL in the early stages of PPH is a strong predictor that the patient will progress to severe hemorrhage requiring massive transfusion. This is tested as a priority assessment finding. When a question asks which lab value is most concerning in a patient with PPH, the fibrinogen level — not the hemoglobin — is the highest-yield early warning indicator.
5. Do not massage a contracted uterus. This is a classic NCLEX distractor. If the fundus is firm and well-contracted, fundal massage provides no benefit and can cause uterine fatigue and pain. The nursing action for a contracted uterus with ongoing bleeding is to look for a traumatic cause (lacerations, hematoma), not to massage more aggressively.
6. Primary vs. secondary PPH timeframes. Primary PPH occurs within 24 hours of delivery (most commonly in the first hour). Secondary PPH occurs from 24 hours up to 12 weeks postpartum. Secondary PPH is most often caused by retained placental tissue, subinvolution of the uterus, or endometritis. The NCLEX will test whether you can classify the scenario correctly, which determines the likely cause and intervention.
7. Carboprost is contraindicated in asthma. Carboprost (Hemabate) is a prostaglandin F2α analogue with bronchoconstrictive properties. In a patient with asthma, it can precipitate severe bronchospasm. When the question stem describes a patient with asthma who is hemorrhaging, carboprost is not the answer — the correct uterotonic is misoprostol or an alternative agent. This contraindication is tested alongside the methylergonovine/hypertension pairing as the two highest-yield uterotonic NCLEX rules.
Related pages
- OB nursing reference — complete obstetric nursing guide covering labor stages, fetal monitoring, preeclampsia, and more
- Hypertension nursing guide — maternal hypertension, preeclampsia, and antihypertensive management
- Shock nursing reference — hypovolemic shock staging, hemodynamic parameters, and resuscitation priorities
- Nursing lab values cheat sheet — CBC, coagulation studies, fibrinogen, and critical value thresholds
- IV insertion guide — technique for large-bore peripheral IV placement in emergency situations